Posts tagged with 'Campaign'
Posts
In this podcast, Steve McCarney, cold chain technologies specialist with Project Optimize, PATH, shares his insights with Pharma IQ, on how advances in vaccines and emerging markets have impacted the cool chain and will continue to do so. He also assesses the impact of technology innovations on the ...
Webinar now available on Cervical Cancer Action website; Please visit the Cervical Cancer Action Multimedia web page to watch and listen. For more information, please contact [email protected]
[size=14]HPV vaccination in developing countries: Recent lessons from six pilot programs[/si...
Call for Documents on the Effects of New Vaccine Introduction on National Immunization Programs and Health Systems
Robert Steinglass and Mike Favin post this request.
The USAID-funded MCHIP Project (Maternal and Child Health Implementation Project) would very much appreciate your assistance in...
Many thanks to Diana Chang Blanc for sharing this information with us.
Introducing a vaccine: Policy and Programme Considerations
Dear Colleagues,
You may recall a brochure from the June 2010 NUVI Meeting "market place" describing an updated Vaccine Product Menu which would be av...
POST 00912E : JE VACCINE INTRODUCTION 17 April 2006 ________________________________ Vikram Singh (mailto:[email protected]) from India, contributes some information of interest on the introduction of Japanese Encephalitis vaccination in India. The information he requests has been sent to him ...
A big thank you to Kim Kertson, PATH, for this note!
Less than ten years after the creation of the Meningitis Vaccine Project (MVP) the new meningococcal A conjugate vaccine is ready to be introduced in Africa. MenAfriVacTM was licensed by the Indian regulatory authorities in December 2009, prequ...
Dear Friends,
A Modeling Study concludes that new vaccines could substantially reduce TB incidence and mortality. Similarily, I strongly feel that the recent 31% success with the new HIV vaccine could have been further enhanced if given in conjunction with ART. Please see the link below: http://www...
Dear Friends,
The introduction of the pentavalent vaccine will further eat into the health budget as shown by Natasha Hsi, Abt Associates, Katherine Wolf, Emory University, Global Health Council (June 2, 2005). The study says that, with the introduction of the pentavalnent vacc...
Dear Friends, Recently there have been a number of articles critical of the recommendations for pneumococcal and the pentavalent vaccines in high impact journals. I understand some of this has spilled over to the lay press and it will be good if we can have clarity on these issu...
The third meeting on New and Underutilised Vaccine Implementation organised by WHO was held in Montreux, Switzerland from 16-19 June. There were 120 participants.
Nine workshops were held covering various aspects like Surveillance, Preferred vaccine presentations, Coordination Between National Regul...
Dear moderator:
As you may know, since November 2007, IMMUNIZATIONbasics project,
along with other partners, started to provide extensive technical
support to the National Immunization Program (NIP) in Rwanda, helping
technical staff with the preparation of pneumococcal conjugate vaccine
introduct...
POST 01424E: INTRODUCE NEW VACCINES BUT WHAT ABOUT ACCESSIBILITY TO OLDER ESSENTIAL VACCINES?
30 APRIL 2009
******************************************
Dear Moderator,
I saw the mail for RFP for newer vaccines but what about accessibility to older essential vaccines in the devel...
Demonstration Projects to Evaluate Innovative System Changes by Carol Levin, Senior Health Economist, PATH Starting in 2009, Optimize will begin large-scale demonstration projects with four collaborating countries and conduct operational research with several others to build an evidence base for the...
POST 01384E: EXPERIENCES OF INTRODUCING HPV
5 FEBRUARY 2009
******************************************
Can anyone share their experience of introducing HPV in their countries? Especially those in the SEARO Region.
Thanks
Karma Tshering ([[email protected]][email protected][...
POST 01384E: EXPERIENCES OF INTRODUCING HPV
5 FEBRUARY 2009
******************************************
Can anyone share their experience of introducing HPV in their countries? Especially those in the SEARO Region.
Thanks
Karma Tshering ([[email protected]][email protected][...
POST 01385E: EXPERIENCES OF INTRODUCING HPV VACCINE
5 FEBRUARY 2009
******************************************
Inadvertently omitted 'vaccine' from the post title, therefore reposting the contribution. No intention of encouraging bio-terrorism. Entirely an error of omission. Many apologies. ...
POST 01385E: EXPERIENCES OF INTRODUCING HPV VACCINE
5 FEBRUARY 2009
******************************************
Inadvertently omitted 'vaccine' from the post title, therefore reposting the contribution. No intention of encouraging bio-terrorism. Entirely an error of omission. Many apologies. ...
POST 01379E: POLIO—THE FINAL INCH
26 JANUARY 2009
******************************************
This posting has two interesting links to the polio eradication vs. control debate.
The first one, to an article that very efficiently sums up the primary factors in the debate: Polio’s Last Stand...
POST 01368E: TECHNICAL SHEETS FOR POLIO OUTBREAKS
2 JANUARY 2009
******************************************
Hans Everts ([[email protected]][email protected][/email]) shares with TechNet21 readers the link to a number of guidelines and standard SOP on outbreak response activities follo...
POST 01363E: TECHNET21 SATELLITE SESSION PRESENTATION: PROJECT OPTIMIZE 16 DECEMBER 2008
******************************************
Prior to the main session, a satellite session titled Optimize future logistics systems: Overview of Project Optimize was held on 1 December 2008. Use the follo...
There are no discussions available here currently